You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / LINCOLN PHARMACEUTICALS LTD

LINCOLN PHARMACEUTICALS LTD Analysis

Returns | 1W : -2.6% , 1M : -0.7%,1Y : 13.8%
BOM : 531633     NSE : LINCOLN    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Jan 22,2021
Price(EOD): Rs. 223.90
This is the End-of-Day (EOD) Stock Price updated daily by 10 pm IST.
MarketCap: Rs. 447.80 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
LINCOLN PHARMACEUTICALS LTD -2.6% -0.7% 13.8%
SUN PHARMACEUTICAL INDUSTRIES LTD -1.1% 0.1% 30.6%
DR REDDYS LABORATORIES LTD -0.4% -3.6% 65.1%
DIVIS LABORATORIES LTD -0.6% -3.9% 94.4%
CIPLA LTD 0.8% -2% 72.3%
BIOCON LTD -12.3% -18.6% 51%
AUROBINDO PHARMA LTD 0.8% 3.8% 81.4%
LUPIN LTD 1.6% 12.1% 44.7%
TORRENT PHARMACEUTICALS LTD 2.1% -3.9% 37%

FUNDAMENTAL ANALYSIS OF LINCOLN PHARMACEUTICALS LTD

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than LINCOLN PHARMACEUTICALS LTDPremium

As on 22-Jan-2021, the Fundamentals of LINCOLN PHARMACEUTICALS LTD are Average and hence you can wait for the results to improve to invest for long term ! See Financial Performance of LINCOLN PHARMACEUTICALS LTD. Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!


VALUATION OF LINCOLN PHARMACEUTICALS LTD

 
Valuation Score
RatioValue
P/E
P/B
P/S
9.04
P/E Calculated based on EPS of 24.78
[ Mar2020 - Standalone Results ]

1.47
P/B Calculated based on Book Value of 152.25
[ Mar2020 - Standalone Results ]

1.17
P/S Calculated based on Revenues of 382.532 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than LINCOLN PHARMACEUTICALS LTDPremium

As on 22-Jan-2021, LINCOLN PHARMACEUTICALS LTD is Fairly Valued and investors can wait for the buying opportunity once it becomes under valued!


INTRINSIC VALUE OF LINCOLN PHARMACEUTICALS LTD

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-6%
-15%
-2%

As on 22-Jan-2021, the Intrinsic Value of LINCOLN PHARMACEUTICALS LTD is Rs. 237.58 determined based on Median of the 3 historical models.
Fair Value based on Median EV / EBIDTA Model : Rs. 237.58
Fair Value based on Median EV / Sales Model : Rs. 263.32
Fair Value based on Median Price / Sales Model : Rs. 229.52
Median Fair Value of LINCOLN PHARMACEUTICALS LTD : Rs. 237.58

As on 22-Jan-2021, LINCOLN PHARMACEUTICALS LTD is trading at a Discount of -6% based on the Median Intrinsic Value!


SHARE PRICE MOMENTUM OF LINCOLN PHARMACEUTICALS LTD

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.02
0.13
0.26
0.14
0.02
0.12
0.27
0.14
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
21.04%
29.46%
32.51%
34.75%
10.57%
13.85%
15.98%
12.28%
QtrlyTrend
8
Latest Qtr: Sep2020




Open Demat Account & Start Investing
    Affiliate Links

Disclosure

The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].
All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z